Stock listing

A2QLX7 Stock Price, News, Filings & Events — Zevra Therapeutics, Inc.

Selected listing: A2QLX7 · LS · EUR · DE

The selected listing A2QLX7:LS represents Zevra Therapeutics, Inc., a biopharmaceutical company focused on developing innovative treatments for rare diseases. Recently, the company has been active in advancing its clinical programs and has provided updates on its research initiatives. Investors can find relevant news, regulatory filings, and upcoming events that may impact the company's market position. Zevra Therapeutics continues to navigate the evolving landscape of the biopharmaceutical sector, aiming to address unmet medical needs.

A2QLX7:LSEURDEUpdated July 31, 2026
Zevra Therapeutics, Inc. logo
Ticker
A2QLX7:LS
Asset type
Stock
Market cap
$562.2M
Sector
Health Technology
Industry
Pharmaceuticals: Major
Exchange
LS
Currency
EUR

Zevra Therapeutics, Inc. A2QLX7:LS stock context

The selected listing A2QLX7:LS represents Zevra Therapeutics, Inc., a biopharmaceutical company focused on developing innovative treatments for rare diseases. Recently, the company has been active in advancing its clinical programs and has provided updates on its research initiatives. Investors can find relevant news, regulatory filings, and upcoming events that may impact the company's market position. Zevra Therapeutics continues to navigate the evolving landscape of the biopharmaceutical sector, aiming to address unmet medical needs.

Research Zevra Therapeutics, Inc.

Alternate listings